REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN

Ping Tepper,Jack Mardekian,Cristina Masseria,Ruslan Horblyuk,Shital Kamble,Melissa Hamilton,Younos Abdulsattar,William Petkun,Gregory Y.H. Lip

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2016）

引用 3|浏览14

暂无评分

摘要

Information about the risk of bleeding and bleeding-related resource use and costs among non-Vitamin K antagonist oral anticoagulants (NOACs) in the real-world setting is scarce. This study aim was to compare inpatient bleeding risks, bleeding-related hospitalization rates and costs among non-

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要